A First-in-Human Single and Multiple Ascending Dose Study of MT-201

NCT07219368 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: MT-201
DRUG: Placebo

Sponsor

Mirador Therapeutics, Inc.